Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #6885
Reference
MSAN(2020)30
Name
Ativan® (lorazepam) 4mg/mL solution for injection
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
SUPPLIES
Description
1. Ativan® (lorazepam) 4mg/mL solution for injection will be out of stock from w/c 27th April until w/c 15th June 2020.
2. The US product, lorazepam injection 2mg/mL, supplied in Carpuject™ single dose cartridges will be available to Boards from early May 2020 on an ‘unlicensed’ basis.
3. Carpuject™ single dose cartridges can be considered bioequivalent to the UK brand Ativan® (lorazepam) 4mg/mL solution for injection and no dosing adjustments should be required.
4. Carpuject™ cartridges must be used in combination with the Carpuject™ holder provided. Injection in cartridge is diluted with an equal volume of compatible solution for IV administration (IM injection is administered undiluted). More information on Carpuject™ single dose cartridges can be found in Annex A.
5. Ativan® (lorazepam) 4mg/mL solution for injection supplies will remain available for primary care customers throughout this period.
2. The US product, lorazepam injection 2mg/mL, supplied in Carpuject™ single dose cartridges will be available to Boards from early May 2020 on an ‘unlicensed’ basis.
3. Carpuject™ single dose cartridges can be considered bioequivalent to the UK brand Ativan® (lorazepam) 4mg/mL solution for injection and no dosing adjustments should be required.
4. Carpuject™ cartridges must be used in combination with the Carpuject™ holder provided. Injection in cartridge is diluted with an equal volume of compatible solution for IV administration (IM injection is administered undiluted). More information on Carpuject™ single dose cartridges can be found in Annex A.
5. Ativan® (lorazepam) 4mg/mL solution for injection supplies will remain available for primary care customers throughout this period.
Contact Name
Contact Email
Contact Address
Created
2020-05-01 00:00:00
Click to go back to homepage